A SINGLE CENTER, OPEN LABEL, FIXED SEQUENCE STUDY TO INVESTIGATE THE EFFECT OF MULTIPLE DOSE BITOPERTIN ON SINGLE DOSE PHARMACOKINETICS OF MIDAZOLAM IN HEALTHY VOLUNTEERS

Trial Profile

A SINGLE CENTER, OPEN LABEL, FIXED SEQUENCE STUDY TO INVESTIGATE THE EFFECT OF MULTIPLE DOSE BITOPERTIN ON SINGLE DOSE PHARMACOKINETICS OF MIDAZOLAM IN HEALTHY VOLUNTEERS

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 14 Sep 2015

At a glance

  • Drugs Bitopertin (Primary) ; Midazolam
  • Indications Obsessive-compulsive disorders; Schizophrenia
  • Focus Pharmacokinetics
  • Sponsors Roche
  • Most Recent Events

    • 14 Oct 2014 Status changed from not yet recruiting to withdrawn prior to enrolment, as per ClinicalTrials.gov record.
    • 27 Jan 2014 Planned End Date changed from 1 Feb 2014 to 1 Mar 2014 as per ClinicalTrials.gov record.
    • 27 Jan 2014 Planned initiation date changed from 1 Jan 2014 to 1 Feb 2014 as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top